Research Article

Characterization of m6A Methylation Modification Patterns in Colorectal Cancer Determines Prognosis and Tumor Microenvironment Infiltration

Figure 8

Evaluation of the performance of m6Ascore for predicting the clinical benefit of immunotherapy in patients with CRC. (a–d) Boxplot depicting differences in the four immunophenoscores between high- and low-m6Ascore subgroups. (e) Differences in m6Ascore among different clinical response subgroups in the IMvigor210 cohort. (f) OS curves between high- and low-m6Ascore subgroups in the IMvigor210 cohort. (g) Differences in clinical responses between high- and low-m6Ascore subgroups in the IMvigor210 cohort. (h) Differences in m6Ascore among different clinical response subgroups in the GSE78220 cohort. (i) OS curves between high- and low-m6Ascore subgroups in the GSE78220 cohort. (j) Differences in clinical responses between high- and low-m6Ascore subgroups in the GSE78220 cohort.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)
(j)